Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-23
DOI
10.3389/fimmu.2022.872910
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy
- (2022) Evelien A. J. van Genugten et al. Frontiers in Oncology
- Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux
- (2022) Brandon C. Jones et al. CANCER AND METASTASIS REVIEWS
- Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer
- (2021) Xiaoqing Luo et al. Cancer Cell International
- DTYMK promote hepatocellular carcinoma proliferation by regulating cell cycle
- (2021) Tianhao Zhou et al. CELL CYCLE
- Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
- (2021) Jie Mei et al. Journal of Inflammation Research
- Contribution of Lipid Oxidation and Ferroptosis to Radiotherapy Efficacy
- (2021) Ashley N. Pearson et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy
- (2020) Tiantian Guo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
- (2020) Sreya Bagchi et al. Annual Review of Pathology-Mechanisms of Disease
- The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
- (2020) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5
- (2020) Zheng Zhu et al. ONCOLOGY REPORTS
- Engineering IL-2 to Give New Life to T Cell Immunotherapy
- (2020) Willem W. Overwijk et al. Annual Review of Medicine
- Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
- (2019) Michael Platten et al. NATURE REVIEWS DRUG DISCOVERY
- UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis
- (2019) Xiongjun Wang et al. NATURE
- PRMTs and Arginine Methylation: Cancer’s Best-Kept Secret?
- (2019) James Jarrold et al. TRENDS IN MOLECULAR MEDICINE
- BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition
- (2019) Xiaofeng Ding et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells
- (2019) Pei-Hsuan Chen et al. MOLECULAR CELL
- Tumor Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation.
- (2019) Patricia Fernandez-Nogueira et al. CLINICAL CANCER RESEARCH
- EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
- (2019) Shunli Peng et al. Molecular Cancer
- The therapeutic potential of targeting tryptophan catabolism in cancer
- (2019) Christiane A. Opitz et al. BRITISH JOURNAL OF CANCER
- A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
- (2019) Hee Chan Yoo et al. Cell Metabolism
- Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
- (2018) Linchong Sun et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
- (2018) Liqin Wang et al. CELL
- Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours
- (2018) Javier Garcia-Bermudez et al. NATURE CELL BIOLOGY
- Aspartate is an endogenous metabolic limitation for tumour growth
- (2018) Lucas B. Sullivan et al. NATURE CELL BIOLOGY
- xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
- (2018) Xiangming Ji et al. ONCOGENE
- Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma
- (2018) Yuanyuan Zhao et al. Cell Death & Disease
- Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis
- (2018) Alexandre Vallée et al. Frontiers in Immunology
- Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer
- (2018) Puneeth Iyengar et al. JAMA Oncology
- Natural and modified IL-2 for the treatment of cancer and autoimmune diseases
- (2018) Masayuki Mizui CLINICAL IMMUNOLOGY
- Inhibition of NF-κB improves sensitivity to irradiation and EGFR-TKIs and decreases irradiation-induced lung toxicity
- (2018) Rong Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Downregulation of fibroblast growth factor 5 inhibits cell growth and invasion of human nonsmall-cell lung cancer cells
- (2018) Yanjuan Zhou et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response
- (2018) John M. Floberg et al. SEMINARS IN RADIATION ONCOLOGY
- Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
- (2017) Ahmed Salem et al. JNCI-Journal of the National Cancer Institute
- Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
- (2017) Ahmed Salem et al. JNCI-Journal of the National Cancer Institute
- Radiotherapy combination opportunities leveraging immunity for the next oncology practice
- (2016) Fernanda G. Herrera et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Role of NF-κB Inhibitors in Cell Response to Radiation
- (2016) Sajjad Molavi Pordanjani et al. CURRENT MEDICINAL CHEMISTRY
- Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment
- (2015) S. Bazzocco et al. CLINICAL CANCER RESEARCH
- Metabolic pathways promoting cancer cell survival and growth
- (2015) Lindsey K. Boroughs et al. NATURE CELL BIOLOGY
- Butyrate and Colorectal Cancer: The Role of Butyrate Transport
- (2013) Pedro Gonçalves et al. CURRENT DRUG METABOLISM
- New Radiotherapy and Chemoradiotherapy Approaches for Non–Small-Cell Lung Cancer
- (2013) Joseph K. Salama et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer
- (2013) Y. Liu et al. Cancer Discovery
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More